EasyManua.ls Logo

BD FocalPoint GS - Page 81

Default Icon
242 pages
Print Icon
To Next Page IconTo Next Page
To Next Page IconTo Next Page
To Previous Page IconTo Previous Page
To Previous Page IconTo Previous Page
Loading...
Generating BD FocalPoint™ GS Review Station Reports
81
NOTE
This information will only be displayed if the Evaluation function is
used.
Column name Definition
Archive Date This column displays the date and time of the archive.
Archived Slides This column displays the number of slides archived.
NFR This column displays the number of slides in this archive
that were designated as NFR (No Further Review) by the
BD FocalPoint™ Slide Profiler.
Note: This column displays 0 for BD SurePath™ slides in
the United States because the BD FocalPoint™ GS
Imaging System combined with
No Further Review is not
available.
NILM This column displays the number of slides in this archive
that were designated as NILM (negative for intraepithelial
lesion or malignancy) by a BD FocalPoint™ GS Review
Station user.
ASC-US This column displays the number of slides in this archive
that were designated as ASC-US (atypical squamous
cells of undetermined significance) by a BD FocalPoint™
GS Review Station user.
ASC-H This column displays the number of slides in this archive
that were designated as ASC-H (atypical squamous cells
cannot exclude HSIL) by a BD FocalPoint™ GS Review
Station user.
LSIL This column displays the number of slides in this archive
that were designated as LSIL (low-grade squamous
intraepithelial lesion) by a BD FocalPoint™ GS Review
Station user.
HSIL This column displays the number of slides in this archive
that were designated as HSIL (high-grade squamous
intraepithelial lesion) by a BD FocalPoint™ GS Review
Station user.
HSIL - Invasion
Suspected
This column displays the number of slides in this archive
that were designated as HSIL, with features suspicious
for invasion by a BD FocalPoint™ GS Review Station
user.
Cancer This column displays the number of slides in this archive
that were designated as squamous cell carcinoma by a
BD FocalPoint™ GS Review Station user.

Table of Contents